Bausch & Lomb Corp. (BLCO) Not Impacted by Xifaxan Loss, Buy Weakness - Cowen
Tweet Send to a Friend
Cowen analyst Ken Cacciatore reiterated an Outperform rating and $35.00 price target on Bausch & Lomb Corp. (NYSE: BLCO) saying ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
